<DOC>
	<DOCNO>NCT00992212</DOCNO>
	<brief_summary>This present study , phase II , open label study evaluate immunogenicity , tolerability safety adjuvanted , inactivate Novel Swine Origin A/H1N1 Monovalent Subunit Influenza Virus Vaccine healthy subject age 18 year . This study explore effect previous concomitant exposure seasonal influenza vaccination immunogenicity safety profile two different dos adjuvanted H1N1sw vaccine .</brief_summary>
	<brief_title>Immunogenicity , Tolerability Safety One Two Doses Adjuvanted Swine-origin A H1N1 Influenza Vaccine Healthy Subjects 18 More Years Age Both Vaccinated Not Yet Vaccinated Against Seasonal Influenza 2009/10</brief_title>
	<detailed_description>At enrolment , subject stratify two age stratum ( 18 60 year , 60 year ) . Total duration study eight week , include two week enrolment 6 week study participation . Vaccinations administer day 1 day 22 . Blood sample collect day 1 ( baseline , first vaccination ) , day 22 ( second vaccination ) , day 29 ( one week second vaccination ) day 43 ( three week second vaccination ) . Sera test Hemagglutination Inhibition ( HI ) Microneutralization ( MN ) assay . Safety assess 3 week first second vaccination .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . For study Groups A B : subject age 18 year day enrollment , take part seasonal trial 2009/10 vaccine registration ; For study Groups C E : subject age 18 year day enrollment , yet expose current seasonal formulation ( 2009/10 NH ) influenza vaccine ; 2 . Individuals good health determine medical history , physical examination clinical judgment investigator ; 3 . Documented consent obtain nature study explain accord local regulatory requirement ; 4 . Individuals able comply study procedure available clinic visit schedule study . 5 . Willingness allow serum sample store beyond study period , potential additional future test good characterize immune response . 1 . Individuals able comprehend follow require study procedure ; individual behavioral cognitive impairment psychiatric disease , opinion investigator , may interfere subject 's ability participate study ; 2 . Individuals history illness , opinion investigator , might interfere result study pose additional risk subject due participation study ; 3 . Individuals receive influenza vaccine 2009/10 NH influenza season ( subject include Groups C E ) prior Visit 1 ; 4 . Individuals document confirm suspected influenza disease within 6 month prior Day 1 . 5 . Receipt another investigational agent within 4 week prior enrollment , completion safety followup period another study ; 6 . Individuals receive vaccine within 4 week prior enrollment study individual ever receive blood , blood product and/or plasma derivative past 12 week ; 7 . Individuals axillary temperature ≥ 38.0°C within 3 day study vaccination ; 8 . Known suspected impairment/alteration immune function , example resulting : receipt immunosuppressive therapy , cancer chemotherapy , receipt immunostimulants within 60 day prior Visit 1 , receipt parenteral immunoglobulin preparation , blood product , and/or plasma derivative within 3 month prior Visit 1 plan full length study , know HIV infection HIVrelated disease . 9 . Surgery plan study period ; 10 . If female , childbearing potential , use `` acceptable contraceptive method '' least 2 month prior study entry ; 11 . Females pregnant nursing ( breastfeed ) mother , female childbearing potential sexually active use plan use acceptable birth control measure first 3 week vaccination . 12 . Members research staff relatives ( research staff individual direct indirect contact trial subject , study site personnel access study document contain subject information , include : e.g . receptionist , person schedule appointment make screen call , regulatory specialist , laboratory technician ) ; hospital personnel health care provider involve study enrol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Pandemic influenza</keyword>
	<keyword>vaccine</keyword>
</DOC>